Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $618.9400 (0.11%) ($607.7400 - $620.3900) on Mon. Feb. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.62% (three month average) | RSI | 50 | Latest Price | $618.9400(0.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(41%) IWD(40%) XLV(40%) SPY(38%) | Factors Impacting REGN price | REGN will decline at least -0.81% in a week (0% probabilities). VIXM(-20%) TBT(-9%) UUP(-8%) VXX(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.81% (StdDev 1.62%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $619.29 | 5 Day Moving Average | $611.93(1.15%) | 10 Day Moving Average | $618.38(0.09%) | 20 Day Moving Average | $619.29(-0.06%) | To recent high | -7.7% | To recent low | 4% | Market Cap | $65.625b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |